Respiratory Syncytial Virus (RSV) Infections drugs in development, 2023

GlobalData tracks 184 drugs in development for Respiratory Syncytial Virus (RSV) Infections by 144 companies/universities/institutes. The top development phase for Respiratory Syncytial Virus (RSV) Infections is preclinical, with 92 drugs in that stage.

Opinion | Immediate Test Result Access: The Good, the Bad, and the Complicated

Fred Pelzman is an associate professor of medicine at Weill Cornell, and has been a practicing internist for nearly 30 years. He is medical director

September 17, 2024

Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot | Psychedelic Invest

FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (“FSD Pharma” or the “Company“), is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions. The

January 17, 2024

Targeted Combination Shows Promise in Metastatic Kidney Cancer

LOUISVILLE, Ky. — More than half of patients with newly diagnosed metastatic kidney cancer responded to a novel drug combination, which held disease progression at

November 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.